Health Care M&A Weekly Deals, The Week Ending January 19, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Context Therapeutics Worldwide rights to Apristor N/A eHealth Acquirer Target Price Change Healthcare National Decision Support Company N/A Elsevier Via Oncology N/A eHealth, Inc. Health, Wealth and Life... Read More »Health Care M&A Weekly Deals, The Week Ending January 12, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Five Arrows Capital Partners The Stepping Stones Group N/A Biotechnology Acquirer Target Price Zymergen Inc. Radiant Genomics N/A Agilent Technologies Inc. Luxcel Biosciences N/A Celgene... Read More »Health Care M&A Weekly Deals, The Week Ending January 5, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Pfizer Inc. Collaboration on PROTACs N/A Roche Research collaboration on novel bispecific molecule $10 million Biocrates Life Sciences AG Metanomics Health GmbH N/A Reckitt... Read More »Stat of the Week: December 2017 +23%
Talk about saving the best for last. For months, deal volume has stagnated, slipped, and failed to excite. Then December happened. Six deals with prices over $1 billion were announced, and their combined value was $91.7 billion. Of course, the CVS/Aetna (NYSE: CVS/AET) deal accunted for most of that, at $77 billion. But what counts is that these deals showed the game is changing in the healthcare market, and market forces and investors are working outside the usual Medicare/Medicaid reimbursement policies. Let’s start with December’s deal volume. At 121 transactions (so far, more will undoubtedly be added), the total is up 23% compared with November’s 98 transactions, but 5% lower than the... Read More »
Q4:17 Redefined Healthcare M&A
Despite all the big deals announced in December, the fourth quarter of 2017 wasn’t one for the record books. Merger and acquisition activity was busy, but compared with the previous quarter and the same period in 2016, the pace wasn’t frenetic. Our preliminary data shows 357 transactions were announced in Q4:17, down a slight 4% compared with the third quarter of 2017, and down 8% versus the fourth quarter of 2016. Dollar volume, on the other hand, was quite high. Preliminary data (again) shows nearly $114.3 billion was spent in Q4:17, a 165% gain over Q3:17, and nearly 200% over Q4:16. That total rests largely on the back of a single deal, which you’ve probably heard... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
